|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.5400 - 0.5604|
|52 Week Range||0.4440 - 1.2600|
|Beta (3Y Monthly)||8.36|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") today announced the official opening of LAB001, the flagship retail location of its wholly- owned subsidiary, Kolab Project Inc. (“Kolab”). LAB001, located at #7, 3427 - 50 Avenue in Lloydminster, Saskatchewan, is open and operational as of July 11, 2019. In conjunction with the opening of the retail location, Kolab is now able to commence province-wide e-commerce sales in Saskatchewan.
The cannabis revolution is just getting started, but the real money is being made behind the scenes, right under the noses of some of the industry’s most savvy investors
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") is pleased to announce the appointment of Andrew MacMillan as Vice President, Commercial Business Development. Mr. MacMillan most recently served as the Chief Executive Officer of the PEI Liquor Control Commission, which is responsible for the regulation and sale of cannabis through its related corporation, the Cannabis Management Corporation. In his role as CEO, Mr. MacMillan oversaw the regulation of cannabis and the establishment of the PEI Cannabis retail operations, which are regarded as among the most successful in the country.
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly") is pleased to announce that Auxly’s wholly owned subsidiary, Dosecann Inc. (“Dosecann”) has entered into a definitive agreement with Capsugel Inc., a subsidiary of Lonza Group Ltd. (“Capsugel”), to provide Dosecann with a complete line of equipment for capsule filling and sealing, including a state-of-the-art LEMS® machine, Lonza’s proprietary liquid-filled Capsugel® Licaps® capsules, and rights to its capsule filling and sealing LEMS® technology. In addition, Dosecann and Lonza will work collaboratively on new product formulation for cannabis capsule products. Lonza’s technology is currently used for several functional improvements in health and nutritional applications, including bioavailability enhancement, taste and odor masking, combination products, and controlled and delayed release.
NEW YORK , June 4, 2019 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the launch of the OTCQX® Cannabis Index ...
Auxly recorded its first marijuana sales in Q1, but revenue isn't expected to really pick up until October.
VANCOUVER, British Columbia, May 27, 2019 -- Auxly Cannabis Group Inc. (TSX.V - XLY) (OTCQX: CBWTF) ("Auxly" or the "Company") today released its financial results for the.
Cannabis cultivation requires enormous amounts of energy, and water, and the companies that employ smart solutions are now pulling ahead in the highly competitive cannabis boom
HENDERSON, NV / ACCESSWIRE / April 9, 2019 / With some analysts calling for a potential recession, they are predicting the cannabis industry will be one of the top industries capable of delivering a healthy ...
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") today announced that its wholly-owned subsidiary, Robinsons Cannabis Inc. (“Robinsons”), has been granted standard cultivation and processing licences by Health Canada pursuant to the Cannabis Act and Cannabis Regulations. The licences give Robinsons the ability to begin cultivation at its fully constructed 27,700 square-foot facility in Kentville, Nova Scotia, which was purpose-built to produce high-quality cannabis. Led by experienced head grower Andrew Robinson, Robinsons is uniquely positioned to capture the attention of luxury cannabis consumers, with operations built on a devotion to uncompromising quality and a premium cannabis experience.
With its ducks now in a row, Auxly readies itself to sell raw cannabis and derivative products in 2019.
Auxly Cannabis Group Inc. (XLY.V) (CBWTF) ("Auxly" or the "Company") today released its fourth quarter and full year 2018 financial results. The Company’s state-of-the-art processing facility at its wholly owned subsidiary Dosecann Inc. (“Dosecann”) and its highly-skilled team give the Company the ability to turn raw cannabis into derivative cannabis products.
In addition to lessened volatility, ancillary cannabis companies are not bogged down by bureaucratic limitations and have more freedom to make strategic acquisitions to bolster their portfolios. All in all, investors looking for potential opportunities could benefit from focusing on the cannabis industry in the coming months. Leafbuyer Technologies Inc (OTC:LBUY), Aphria Inc (NYSE: APHA, TSX: APHA), Auxly Cannabis Group Inc (CBWTF), and The Supreme Cannabis Company Inc (SPRWF) represent 4 marijuana stocks worth keeping on your radar on Tuesday.
HENDERSON, NV / ACCESSWIRE / March 20, 2019 / With cannabis in the news and investors becoming more and more hungry for the next big winner in the industry, we decided to highlight a couple that could ...
VANCOUVER, British Columbia, March 18, 2019 -- Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") today announced that it plans to report its fourth quarter and.
CORAL GABLES, FL / ACCESSWIRE / March 18, 2019 / The marijuana stock market has demonstrated in the first few months of 2019 that the cannabis industry, despite its nascent characteristics, is very much a force to be reckoned with. As a result of lawmakers advocating for, and subsequently passing, legislation in favor of cannabis legalization, companies in the industry have made key investments in products and services, all of which for the purpose of giving all benefits to the consumer. Considering that marijuana is currently flagged as a Schedule I narcotic by the U.S. government, one would assume that this would dampen the progress of the cannabis sector, but, in fact, cannabis companies are showing no signs of slowing down.
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") today announced that its streaming partner, Lotus Ventures Inc. (“Lotus”), has been granted a “standard cultivation” licence and a “sale for medical purposes” licence by Health Canada pursuant to the Cannabis Act and Cannabis Regulations. The licences give Lotus the ability to begin cultivation at its fully constructed 22,500 square-foot facility in Armstrong, British Columbia (the “Facility”). Hugo Alves, President of Auxly said: “We want to congratulate Dale, Stephen, Scott, Carl, Monica and the rest of the Lotus team on obtaining their Cannabis Act licences! This is an important step for Auxly as we continue to diversify our supply chain, utilizing a network of subsidiaries and partners to provide reliable sources of diverse raw product.
CORAL GABLES, FL / ACCESSWIRE / February 26, 2019 / The marijuana stock market has consistently dominated headlines with news related to positive gains in the market, despite volatile conditions felt by ...
CORAL GABLES, FL / ACCESSWIRE / February 14, 2019 / What's incredible about the marijuana stock market is the sheer amount of excitement surrounding companies in the cannabis industry. As we've seen over the course of the past few years, more countries have brought forth legislation in favor of legalizing marijuana for recreational, as well as medicinal, purposes, and as a result, companies in the space have seen an influx in investor attention. If companies continue like this, the marijuana industry may see impressive gains as a result of favorable public opinions.